Retraction: SHCBP1 promotes papillary thyroid carcinoma carcinogenesis and progression through promoting formation of integrin and collagen and maintaining cell stemness
- 1Department of Endocrinology, Affiliated Hospital of Medical College of Southeast University and Xuzhou Central Hospital, Xuzhou, China
- 2Xuzhou Clinical School, Xuzhou Medical University, Xuzhou, China
- 3Xuzhou Clinical School, Nanjing Medical University, Xuzhou, China
- 4Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China
- 5Cancer Institute, Xuzhou Medical University, Xuzhou, China
- 6Xuzhou Institute of Medical Science, Postgraduate Workstation of Soochow University, Xuzhou, China
Citation: Geng H, Guo M, Xu W, Zang X, Wu T, Teng F, Wang Y, Liu X, Wang X, Sun Q and Liang J (2021) SHCBP1 Promotes Papillary Thyroid Carcinoma Carcinogenesis and Progression Through Promoting Formation of Integrin and Collagen and Maintaining Cell Stemness. Front. Endocrinol. 11:613879. doi: 10.3389/fendo.2020.613879
Received: 19 November 2020; Accepted: 31 December 2020;
Published: 26 February 2021; Retracted: 13 February 2024.
Edited by:
Claudio Bellevicine, Federico II University Hospital, ItalyReviewed by:
Fabio Pagni, University of Milano-Bicocca, ItalyMario Vitale, University of Salerno, Italy